<DOC>
	<DOCNO>NCT01928459</DOCNO>
	<brief_summary>To study safety efficacy combination BGJ398 BYL719 patient whose tumor express mutation PIK3CA without alteration FGFR 1-3 .</brief_summary>
	<brief_title>Phase 1b Trial BGJ398/BYL719 Solid Tumors</brief_title>
	<detailed_description>This dose escalation/dose expansion study evaluate combination orally administer BGJ398 combination orally administer BYL719 . During dose escalation part , MTD combination determine patient whose advanced metastatic tumor express mutation PIK3CA . Once MTD determine , expansion part begin . Patients addd one three arm base disease type genetic change . Patients metastatic colorectal cancer eligible participation expansion part .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Histologically/cytologically confirm advanced metastatic solid tumor fail standard therapy effective standard anticancer therapy exist Documented PIK3CA mutation patient dose escalation expansion without document genetic alteration FGFR depend upon dose expansion cohort ( either local central determination ) Measurable disease define RECIST v1.1 ECOG performance status ≤2 Prior PI3Ki selective FGFR inhibitor treatment ( patient enrol expansion part ) Colorectal cancer ( patient enrol expansion part ) Patients diabetes mellitus require insulin treatment and/or clinical sign fast glucose ≥ 140 mg/dL / 7.8 mmol/L , history clinically significant gestational diabetes mellitus document steroidinduced diabetes mellitus Use medication increase serum level phosphorus and/or calcium Inorganic phosphorus outside normal limit Total ionize serum calcium outside normal limit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>BGJ398</keyword>
	<keyword>BYL719</keyword>
	<keyword>advanced solid tumor</keyword>
	<keyword>metastatic breast cancer</keyword>
	<keyword>PK3CA</keyword>
	<keyword>FGFR</keyword>
	<keyword>fibroblast growth factor receptor</keyword>
</DOC>